Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential… Grant US-11697689-B2 United States of America 11 Jul 2023
NEW METHOD TO IMPROVE THE ANTI-TUMORAL ACTIVITY OF MACROPHAGES Application WO-2022219076-A1 World Intellectual Property Organisation (WIPO) 20 Oct 2022
NEW METHOD TO IMPROVE NK CELLS CYTOTOXICITY Application WO-2022219080-A1 World Intellectual Property Organisation (WIPO) 20 Oct 2022
HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2) Application EP-4019551-A1 European Patent Office 29 Jun 2022
Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for… Grant US-10745489-B2 United States of America 18 Aug 2020
Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity Grant US-10611848-B2 United States of America 07 Apr 2020
Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for… Application US-10000575-B2 United States of America 19 Jun 2018
HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2) Application WO-2018010846-A1 World Intellectual Property Organisation (WIPO) 18 Jan 2018
HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2) Application EP-3269739-A1 European Patent Office 17 Jan 2018
Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the… Grant US-9334330-B2 United States of America 10 May 2016
USE OF MONOCLONAL ANTIBODIES SPECIFIC TO THE O-ACETYLATED FORM OF GD2 GANGLIOSIDE FOR THE… Application US-20150140023-A1 United States of America 21 May 2015
ANTIBODY AGAINST GD2-O-ACETYLATED GANGLIOSIDE WITH PRO-APOPTOTIC ACTIVITY Application WO-2015067375-A1 World Intellectual Property Organisation (WIPO) 14 May 2015
Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity Application EP-2871190-A1 European Patent Office 13 May 2015